Darifenacin Hydrobromide Darifenacin HBr CAS 133099-07-7 Assay ≥99.0% API Ụlọ ọrụ dị elu
Onye nrụpụta nwere ịdị ọcha dị elu yana ịdị mma kwụsie ike
Aha kemịkal: Darifenacin Hydrobromide
Nọmba: 133099-07-7
Darifenacin hydrobromide bụ onye na-anabata M3 muscarinic antagonist nke a na-eji agwọ ọrịa urinary incontinence na ọrịa eriri afo na-arụ ọrụ.
API Ogo dị elu, mmepụta azụmahịa
| Aha Chemical | Darifenacin Hydrobromide |
| Ụdị okwu | Darifenacin HBr;UK-88525;Enablex |
| Nọmba CAS | 133099-07-7 |
| Nọmba CAT | RF-API94 |
| Ọnọdụ Ahịa | Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms |
| Usoro ihe omimi | C28H30N2O2.HBr |
| Ibu molekụla | 507.46 |
| Ebe Na-agbaze | 228.0 ~ 230.0 ℃ |
| Solubility | DMSO: Soluble 20mg/ml, Clear |
| Okpomọkụ nchekwa | Na-echekwa ogologo oge na -20 ℃ |
| Ụdị | Ruifu Chemical |
| Ihe | Nkọwapụta |
| Ọdịdị | White Crystalline ntụ ntụ |
| Solubility | Na-agbaze obere n'ime methanol, Na-agbaze ntakịrị n'ime mmiri yana enweghị ike ime ya na Chloroform |
| njirimara IR | Spectrum nke sample dabara na nke ọkọlọtọ ntụaka |
| njirimara HPLC | Oge njide nke nnukwu ọnụ ọgụgụ kachasị elu nke ngwọta nlele dabara na nke ọkọlọtọ ọkọlọtọ |
| Ihe ndị emetụtara | |
| Oke.Otu adịghị ọcha | ≤0.50% |
| Mgbakọta adịghị ọcha | ≤1.0% |
| Ngwa anya Isomer | ≤0.50% |
| Ihe mgbaze fọdụrụnụ | |
| Ethyl acetate | ≤0.50% |
| Ethanol | ≤0.50% |
| Methanol | ≤0.30% |
| Acetone | ≤0.50% |
| 1-Butanol | ≤0.50% |
| Ọnwụ na ihicha | ≤1.0% (Akọrọ na 105 ℃ na eletriki ikuku na-afụ nkụ ruo mgbe ịdị arọ) |
| Ihe fọdụrụ na mgbanye | ≤0.10% |
| Ọla dị arọ | ≤20ppm |
| Nyocha | ≥99.0% (na akpọnwụwo ndabere) |
| Ndụ shelf | Ọnwa 24 |
| Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
| Ojiji | API, eriri afọ na-emebiga ihe ókè |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
Darifenacin Hydrobromide, Darifenacin HBr (CAS 133099-07-7), onye na-arụ ọrụ ọnụ, otu ugboro kwa ụbọchị na-ahọrọ onye na-anabata M3 antagonist, maka ọgwụgwọ nke eriri afo na-emebiga ihe ókè na ndị ọrịa nwere mgbaàmà nke mkpali urinary incontinence, ngwa ngwa na ugboro ole.Ọgwụ ahụ na-ahọrọ nke ọma na-egbochi onye na-anabata M3 na akwara detrusor ka ọ na-echekwa M1 na M2 ndị na-anabata ya bụ ndị kwenyere na ha na-etinye aka na usoro nhụjuanya etiti na ọrụ obi.Ọ bụ Pfizer mepụtara ogige a ma nye ya Novartis na Bayer ikike.
